StockNews.com began coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the medical research company’s stock.
Check-Cap Price Performance
NASDAQ:CHEK opened at $1.42 on Wednesday. The firm has a market capitalization of $8.31 million, a P/E ratio of -0.47 and a beta of 0.36. The company’s fifty day moving average price is $1.70 and its 200-day moving average price is $2.02. Check-Cap has a 1-year low of $1.13 and a 1-year high of $3.94.
Check-Cap Company Profile
Read More
- Five stocks we like better than Check-Cap
- Trading Halts Explained
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Why Invest in 5G? How to Invest in 5G Stocks
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What is a Bond Market Holiday? How to Invest and Trade
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.